8-KRegulation FD

CENTENE CORP 8-K Report, Regulation FD Disclosure (Sep 16, 2026)

Filed September 16, 2026For Securities:CNC

Summary

Centene Corporation (CNC) announced its participation in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026, and subsequent investor discussions. Management will reiterate the company's full-year 2026 financial guidance, affirming GAAP diluted EPS expectations of greater than $3.11 and adjusted diluted EPS expectations of greater than $4.80. This filing serves primarily as a disclosure under Regulation FD, ensuring fair and timely information dissemination to investors. The company emphasizes its use of non-GAAP financial measures, such as adjusted diluted EPS, to provide a clearer view of ongoing operational performance. Investors are encouraged to review these non-GAAP measures alongside GAAP results and refer to previous filings for detailed reconciliations. The company also included standard forward-looking statement disclaimers, highlighting the inherent risks and uncertainties associated with future performance projections.

Key Highlights

  • 1Centene Corporation will participate in the Deutsche Bank 2026 Healthcare Summit on September 16, 2026.
  • 2Management will reaffirm full-year 2026 GAAP diluted EPS guidance of greater than $3.11.
  • 3Management will reaffirm full-year 2026 adjusted diluted EPS guidance of greater than $4.80.
  • 4The company utilizes non-GAAP financial measures to provide insight into ongoing operations and performance.
  • 5Investors can access a live audio webcast of the presentation and a replay via Centene's investor relations website.
  • 6The company provided standard forward-looking statement disclosures, outlining potential risks and uncertainties.

Frequently Asked Questions

The primary purpose of this Form 8-K filing is to disclose Centene Corporation's participation in the Deutsche Bank 2026 Healthcare Summit and to reaffirm its financial guidance for the full year 2026. It also serves to inform investors about the availability of a webcast for the presentation.

Centene is reaffirming its full-year 2026 GAAP diluted earnings per share (EPS) guidance to be greater than $3.11 and its full-year adjusted diluted EPS guidance to be greater than $4.80.

Centene provides non-GAAP financial measures, such as adjusted diluted EPS, because it believes these figures are helpful for investors to more accurately assess the ongoing nature of the company's operations and measure performance more consistently across periods. These measures exclude items like amortization of acquired intangible assets and acquisition-related expenses.

Investors can find reconciliations of GAAP diluted EPS to adjusted diluted EPS by referring to the press release filed as Exhibit 99.1 to the Form 8-K on July 28, 2026. Additionally, a webcast replay will be available on Centene's website under the Investors section following the presentation.